January 27, 2020 -Use of the MolecuLight i:X to image for bacterial fluorescence, in conjunction with clinical signs & symptoms, adds an additional bacterial-specific piece of information that can be captured and considered in real-time. Read More
January 27, 2020 -Clinical Synopsis
Patient Condition: 47 year old male required an above knee amputation following a traumatic burn injury. Patient reported severe pain and developed an abscess ~6 weeks post-amputation.
Patient required a right, above knee amputation after severe burns. The stump later became infected, therefore was evacuated, washed out and
… Read MoreJanuary 27, 2020 -Use of the MolecuLight i:X to image for bacterial fluorescence, in conjunction with clinical signs & symptoms, adds an additional bacterial-specific piece of information that can be captured and considered in real-time. Read More
January 27, 2020 -ABSTRACT Introduction:
Amputations amount to $8.3 billion in hospital costs annually in the United States.1 In the general population of England more than 2700 lower limb amputations occur annually, with a mortality rate of 17%.2 Infection is a major potential complication in all wounds, however the highest rate of
… Read MoreJanuary 27, 2020 -ABSTRACT
Colorectal resections have a 4-25% acute surgical site infection rate, despite perioperative best practices for prevention. Repair of abdominal wall hernias carry risks for wound failure and infection. Management of wounds is resource intensive (~70% of home care visits). Care providers assess traditional markers for wound infection (pain,
… Read MoreJanuary 27, 2020 -ABSTRACT Aim:
Real-time, point-of-care detection of critical bacterial colonization relies primarily on subjective visual inspection and clinical signs and symptoms. When wounds are illuminated by violet light, most pathogenic bacterial species emit a unique red fluorescence signal due to the production of endogenous porphyrins, while Pseudomonas aeruginosa uniquely emits
… Read MoreJuly 24, 2019 -ABSTRACT
The persistent presence of pathogenic bacteria is one of the main obstacles to wound healing. Detection of wound bacteria relies on sampling methods, which delay confirmation by several days. However, a novel handheld fluorescence imaging device has recently enabled real-time detection of bacteria in wounds based on their intrinsic
… Read MoreAugust 2, 2017 -ABSTRACT Objective:
Bacteria in chronic wounds are invisible to the naked eye and can lead to delayed wound healing. Point-of-care bacterial fluorescence imaging illuminates a wound with 405 nm light, triggering bacteria to produce red fluorescence and enabling real-time bacterial localization. Prospective, single-blind clinical trials (clinicaltrials.gov #NCT02682069,#NCT03091361) were conducted to
… Read MoreJanuary 23, 2017 -ABSTRACT
Diabetes-related foot disease remains a common problem. For wounds, classic teaching recommends the treatment of any infection, offloading the wound and ensuring a good blood supply, as well as ensuring that the other modifiable risk factors are addressed and optimized. There remain, however, several questions about these and other
… Read More
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.